{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:08:59Z","timestamp":1787508539423,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.leukres.2017.12.010","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T13:04:57Z","timestamp":1514898297000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"65","author":[{"given":"Natalia C.","family":"Millan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00eda","family":"Pastrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam R.","family":"Guitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Zubizarreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda S.","family":"Monges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda S.","family":"Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"August (4 Suppl 2)","key":"10.1016\/j.leukres.2017.12.010_bib0005","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminoncol.2009.05.002","article-title":"Central nervous System Diseasein Hematological Malignancies: Historical Perspective and Practical Applications","volume":"36","author":"Pui","year":"2009","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.leukres.2017.12.010_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/pbc.21212","article-title":"Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia","volume":"50","author":"Lin","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.leukres.2017.12.010_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0145-2126(98)00162-3","article-title":"Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM\u201990 protocol: lack of improvement in high-risk group","volume":"23","author":"Sackmann-Muriel","year":"1999","journal-title":"Leukemia Res."},{"key":"10.1016\/j.leukres.2017.12.010_bib0020","first-page":"92","article-title":"Evoluci\u00e1n en el tratamiento de la leucemia linfobl\u00f3stica aguda en el Hospital de Pediatr\u00eda Prof. Dr. Juan P. Garrahan","volume":"14","author":"Felice","year":"2007","journal-title":"Med. Infant."},{"key":"10.1016\/j.leukres.2017.12.010_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/pbc.23097","article-title":"No advantage of a Rotational Continuation Phase in Acute Lymphoblastic Leukemia in Childhood treated with a BFM back-bone therapy","volume":"57","author":"Felice","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.leukres.2017.12.010_bib0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"Outcome of infants less than one year of age with acute lymphoblastic leukemia treated with the Interfant-99 protocol","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.leukres.2017.12.010_bib0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1200\/JCO.2013.48.6522","article-title":"Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002","volume":"32","author":"Stary","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"March (9)","key":"10.1016\/j.leukres.2017.12.010_bib0040","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.2015.64.2850","article-title":"Influence of cranial radiotherapy on outcomes in children with acute lymphoblastic leukemia treated with contemporary therapy","volume":"34","author":"Vora","year":"2016","journal-title":"J Clin. Oncol."},{"issue":"July (3)","key":"10.1016\/j.leukres.2017.12.010_bib0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1215\/15228517-2007-015","article-title":"Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate Neuro Oncol","volume":"9","author":"Eichler","year":"2007","journal-title":"Neuro-Oncology"},{"issue":"Suppl 1","key":"10.1016\/j.leukres.2017.12.010_bib0050","first-page":"89","article-title":"Neurologic sequelae of methotrexate and ionizing radiation: a new classification","volume":"65","author":"Bleyer","year":"1981","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.leukres.2017.12.010_bib0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000069773","article-title":"Biochemical and clinical aspects of methotrexate neurotoxicity","volume":"49","author":"Vezmar","year":"2003","journal-title":"Chemotherapy"},{"issue":"August","key":"10.1016\/j.leukres.2017.12.010_bib0060","article-title":"Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer","author":"Inaba","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2017.12.010_bib0065","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/sj.leu.2401098","article-title":"Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia","volume":"12","author":"Rubnitz","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.12.010_bib0070","first-page":"159","article-title":"High dose systemic methotrexate associated acute neurologic dysfunction","volume":"11","author":"Packer","year":"1983","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1016\/j.leukres.2017.12.010_bib0075","article-title":"Methotrexate-Induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic","author":"Bhojwani","year":"2018","journal-title":"Leukemia"},{"issue":"no (4)","key":"10.1016\/j.leukres.2017.12.010_bib0080","article-title":"Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment lesley","volume":"21","author":"Mitchell","year":"1995","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"October","key":"10.1016\/j.leukres.2017.12.010_bib0085","article-title":"Thrombosis in children with acute lymphoblastic leukemia Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy","author":"Uma Athalea","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.leukres.2017.12.010_bib0090","unstructured":"Ulrike Nowak-Go \u0308ttl, Gili Kenet, Lesley G. Mitchell, Thrombosis in childhood acute lymphoblastic leukemia: epidemiology, etiology, diagnosis, prevention and treatment; Paediatric Haematology and Oncology, University Hospital M\u00fcnster, Albert-Schweitzer-Str. 33, D48149 M\u00fcnster, Germany b Israel National Haemophilia Centre, Sheba Medical Centre, Tel-Hashomer, Israel, c Stollery Children\u2019s Hospital, Edmonton,Alberta, Canada."},{"key":"10.1016\/j.leukres.2017.12.010_bib0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2141.2005.05528.x","article-title":"Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease","volume":"129","author":"Uma Athalea","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.12.010_bib0100","unstructured":"U Nowak-Go \u0308ttl, E Ahlke, G Fleischhack, D Schwabe, R Schobess, C Schumann, and R Junker Clinical observations, interventions, and therapeutic trials. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration."},{"key":"10.1016\/j.leukres.2017.12.010_bib0105","series-title":"BC Cancer Agency Cancer Drug Manual\u00a9","year":"2008"},{"issue":"11","key":"10.1016\/j.leukres.2017.12.010_bib0110","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1288\/00005537-199211000-00011","article-title":"Vincristine-induced recurrent laryngeal nerve paralysis","volume":"102","author":"Annino","year":"1992","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.leukres.2017.12.010_bib0115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00277-011-1348-3","article-title":"Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia","volume":"91","author":"Bacon","year":"2012","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2017.12.010_bib0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0971-5851.133727","article-title":"Posterior reversible encephalopathy syndrome in pediatric acute leukemia: case series and literature review","volume":"35","author":"Sandhya Appachu","year":"2014","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.leukres.2017.12.010_bib0125","series-title":"Central Nervous System Complications During Treatment of Acute Lymphoblastic Leukemia in a Single Pediatric Institution","author":"Parasole","year":"2010"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617306148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617306148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T14:25:00Z","timestamp":1530195900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617306148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":25,"alternative-id":["S0145212617306148"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.12.010","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}